The inactivation by carbenoxolone of individual human pepsinogens and pepsins.
D000818:Animals; D002417:Cattle; D002918:Chymotrypsin / Q000037:antagonists & inhibitors; D004381:Duodenal Ulcer / Q000201:enzymology; D004789:Enzyme Activation; D005750:Gastric Juice / Q000201:enzymology; D005753:Gastric Mucosa / Q000201:enzymology; D006035:Glycyrrhiza; D006801:Humans; D006863:Hydrogen-Ion Concentration; D066298:In Vitro Techniques; D009994:Osmolar Concentration; D010206:Papain; D010434:Pepsin A / Q000037:antagonists & inhibitors*; D010435:Pepsinogens / Q000037:antagonists & inhibitors*; D010437:Peptic Ulcer / Q000188:drug therapy; D010946:Plants, Medicinal; D011402:Pronase / Q000037:antagonists & inhibitors; D013305:Streptomyces griseus / Q000201:enzymology; D013386:Succinates / Q000494:pharmacology; D013552:Swine; D013696:Temperature; D013997:Time Factors; D014315:Triterpenes / Q000494:pharmacology*; D014361:Trypsin Inhibitors
D010435:Pepsinogens; D013386:Succinates; D014315:Triterpenes; D014361:Trypsin Inhibitors; D002918:Chymotrypsin; D010206:Papain; D010434:Pepsin A; D011402:Pronase